Search Results

The epidemiology of multidrug-resistant organisms in persons diagnosed with cancer in Norway, 2008-2018: expanding surveillance using existing laboratory and register data.

• Authors : Danielsen AS; Department of Microbiology, Oslo University Hospital, Oslo, Norway. .; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. .

Subjects: Methicillin-Resistant Staphylococcus aureus* ; Communicable Diseases* ; Vancomycin-Resistant Enterococci*

• Source: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [Eur J Clin Microbiol Infect Dis] 2024 Jan; Vol. 43Publisher: Springer Country of Publication: Germany NLM ID: 8804297 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1435-4373

Record details

The fight to keep resistance at bay, epidemiology of carbapenemase producing organisms (CPOs), vancomycin resistant enterococci (VRE) and methicillin resistant Staphylococcus aureus (MRSA) in Norway, 2006 - 2017

• Authors : Elstrøm, Petter; Astrup, Elisabeth; Hegstad, Kristin

• Source: PLoS ONE. February 4, 2019, Vol. 14 Issue 2, e0211741

Record details

Findings from A. Brown Gandt and Co-Authors Update Knowledge of Glycopeptide Antibiotics (In Vivo and In Vitro Effects of a ClpP-Activating Antibiotic against Vancomycin-Resistant Enterococci)

• Source: Obesity, Fitness & Wellness Week. June 29, 2019, 1051

Record details

Characterizing vancomycin-resistant enterococci in neonatal intensive care

• Authors : Sherer, C. Rebecca; Sprague, Bruce M.; Campos, Joseph M.

• Source: Emerging Infectious Diseases. Sept, 2005, Vol. 11 Issue 9, p1470, 3 p.

Record details

University of California - Los Angeles Details Findings in Liver Transpls [Practical Methods for Effective Vancomycin-resistant Enterococci (Vre) Surveillance: Experience In a Liver Transplant Surgical Intensive Care Unit]

• Source: Health & Medicine Week. July 12, 2019, 1583

Record details

MRSA and vancomycin-resistant enterococci associated with adverse outcomes.

• Source: Drug Week. 2004, pages. 26

Record details

MRSA and vancomycin-resistant enterococci associated with adverse outcomes.

• Source: Blood Weekly. 2004, pages. 11

Record details

MRSA and vancomycin-resistant enterococci associated with adverse outcomes.

• Source: Immunotherapy Weekly. 2004, pages. 15

Record details

MRSA and vancomycin-resistant enterococci associated with adverse outcomes.

• Source: Health & Medicine Week. 2004, pages. 45

Record details

MRSA and vancomycin-resistant enterococci associated with adverse outcomes.

• Source: AIDS Weekly. 2004, pages. 11

Record details